Genetically engineered live-attenuated cytomegalovirus (CMV) vaccines improve pregnancy outcome in the guinea-pig model of congenital CMV infection
Main Authors: | Cui Xiaohong, Leviton Mike, Anderson Jodi, Choi Yeon, McGregor Alistair, Schleiss Mark R, McVoy Michael |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-04-01
|
Series: | Retrovirology |
Similar Items
-
Intravaginal cytomegalovirus (CMV) challenge elicits maternal viremia and results in congenital transmission in a guinea pig model
by: Schleiss Mark R, et al.
Published: (2011-03-01) -
An Attenuated Cytomegalovirus Vaccine with a Deletion of a Viral Chemokine Gene Is Protective against Congenital CMV Transmission in a Guinea Pig Model
by: Michael P. Leviton, et al.
Published: (2013-01-01) -
Analysis of the nucleotide sequence of the guinea pig cytomegalovirus (GPCMV) genome
by: Cui Xiaohong, et al.
Published: (2008-11-01) -
Cyclic cidofovir (cHPMPC) prevents congenital cytomegalovirus infection in a guinea pig model
by: McGregor Alistair, et al.
Published: (2006-03-01) -
Exciting Times for Cytomegalovirus (CMV) Vaccine Development: Navigating the Pathways toward the Goal of Protecting Infants against Congenital CMV Infection
by: Mark R. Schleiss, et al.
Published: (2020-09-01)